DINESH

EID Parry

Industry: Sugar
Latest CMP 686
Today's Change ▼ -1.49%
52-Week High / Low 1,090 | 686
Price Date: 30-Sep-2026
Recommendation Buy
Target Price 1,238
Expected Upside 34.3%
Forecast Horizon 2 Years
Historical CAGR 14.7%
1,000 Invested 01-Oct-2006
Today's Value 15,395
Investment Period 20 Years

Stock Snapshot

Post Results Return
-3.0%
Mild Negative Re-rating
1-Year Target Price
1,170
2-Year Target Price
1,238
52-Week High / Low
1,090 / 686
20-Day Return
-11.9%
Market Cap (Cr.)
12,202
Current PE
16.5
P/BV Ratio
1.4
Dividend Yield
1.5%
Industry PE
17.9

Price Performance

Vista Outlook

Basis of our Recommendation

E.I.D.- Parry (India) Limited is navigating a complex landscape marked by strategic transformations and external pressures. Management's focus on operational efficiency and balance sheet deleveraging is crucial as they pivot towards margin-accretive products in the Consumer Product Group, aiming for breakeven within 4-5 quarters. The Nutraceuticals segment, particularly the US-based Valensa business, is poised for record revenues, supporting Vista's revenue growth expectations. However, rising cane costs and domestic export restrictions pose significant challenges, potentially impacting margins and revenue. Vista's forecast anticipates moderated revenue growth and continued margin pressure, reflecting these headwinds. The company's strong balance sheet and proactive risk management strategies, including foreign currency hedging, provide a buffer against volatility. Industry dynamics, such as stable pricing power and a shift towards ethanol blending, offer potential upside, yet inflationary pressures and geopolitical uncertainties remain watchpoints. Over the next 12-24 months, key opportunities lie in product innovation and market expansion, while headwinds include rising input costs and the need for effective management of export limitations

👍 Why We Like This Stock

  • Management's focus on operational efficiency and margin-accretive products is expected to enhance profitability
  • The Nutraceuticals segment is showing strong momentum, particularly in the US market, which could drive revenue growth
  • Stable pricing power in the sugar industry and increasing ethanol blending present opportunities for future expansion

⚠ Things To Watch Out For

  • Rising cane costs are exerting pressure on profit margins, potentially impacting overall profitability
  • Domestic export restrictions limit revenue potential and could hinder market share growth
  • Inflationary pressures and geopolitical uncertainties pose risks to the company's financial stability

Key Parameters

Balance Sheet Strength
Strong and Investable
Market Share
Gaining
Industry Outlook
Stable
Analyst View
Not Available
Dividend History
Regular
FII Holdings
Reducing

Financial Snapshot

View Technicals Analysis →
Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 29,413 31,609 38,534 37,926 40,185
Profit Before Tax (Cr.) 2,136 1,999 2,579 2,539 2,690
PBT Margin 7.3% 6.3% 6.7% 6.7% 6.7%
Net Profit (Cr.) 1,588 1,448 1,615 1,904 1,210
Earnings Per Share 48.9 31.1 45.2 64.2 68.0

Analyst Recommendations

No analyst recommendations available.

Consensus Recommendation ► None
Consensus Target —
Coverage 0 Analysts
Analysts' Viewpoint

Company Overview

Show Company Profile

E.I.D.- Parry (India) Limited, together with its subsidiaries, engages in the manufacture and sale of sugar, ethanol, cogeneration, nutraceuticals, and consumer products in India, North America, Europe, and internationally. The company offers sugar for use in food, bakery, confectioneries, beverage, and pharmaceutical industries; and grains, such as millets and dals, as well as rice. It also provides nutraceuticals products, such as organic spirulina and chlorella, carotenoid, astaxanthin, and lutein and zeaxanthin; and distillery products, including extra neutral alcohol, ethanol, etc. In addition, the company offers generates and sells approximately 140 MW of power for state electricity grids and private energy. E.I.D.- Parry (India) Limited was founded in 1788 and is headquartered in Chennai, India.